Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study | Journal of Neurology, Neurosurgery & Psychiatry

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

JNNP 100

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Article metrics

Multiple sclerosis

Research paper

Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study

Online download statistics by month:

Online download statistics by month: March 2018 to December 2020

	Abstract	Full	Pdf
Mar 2018	369	49	3
Apr 2018	1439	419	104
May 2018	336	36	26
Jun 2018	167	23	13
Jul 2018	128	20	9
Aug 2018	158	20	11
Sep 2018	621	100	54
Oct 2018	449	59	42
Nov 2018	354	57	32
Dec 2018	136	20	9
Jan 2019	126	19	12
Feb 2019	165	25	14
Mar 2019	129	17	7
Apr 2019	101	15	6
May 2019	104	13	9
Jun 2019	142	12	9
Jul 2019	82	6	5
Aug 2019	107	16	9
Sep 2019	149	17	15
Oct 2019	194	18	13
Nov 2019	162	20	12
Dec 2019	150	10	4
Jan 2020	102	11	5
Feb 2020	116	14	11
Mar 2020	254	25	12
Apr 2020	235	28	23
May 2020	207	33	29
Jun 2020	232	23	34
Jul 2020	154	7	5
Aug 2020	194	16	18
Sep 2020	205	20	12
Oct 2020	228	23	15
Nov 2020	197	28	11
Dec 2020	112	23	12
Total	8004	1242	605